Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Its remarkably stable and sticks around much longer in the bloodstream
One-time discounts notwithstanding, the price stated upon your initial subscription will always be honored, even if your dosage increases and more vials are needed in subsequent months.
Nov 17: AstraZeneca scored a first-in-class approval for its pan-AKT inhibitor capivasertib as a treatment for adults with hormone receptorpositive and HER2-negative locally advanced or metastatic breast cancer whose tumors also have PIK3CA, AKT1 or PTEN mutations
It can be taken once a day, once a week, or even as and when you feel it is needed
US$ 21.46
US$ 28.55
US$ 24.12
US$ 26.55
US$ 21.91
US$ 25.87
US$ 28.28
US$ 21.97
US$ 22.32
US$ 21.12
US$ 24.15
